Related Experiment Video
Updated: Jun 21, 2026
07:08
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Pancreatic cancer--could it be that simple? A different context of vulnerability
Daniel D Von Hoff1, Ron Korn, Spyro Mousses
1Translational Genomics Research Institute, Phoenix, AZ 85004, USA. dvh@tgen.org
Cancer Cell
|July 4, 2009
Abstract:
In a recent issue of Science, Olive and colleagues document that inhibition of Hedgehog (Hh) signaling in a genetically engineered mouse model of pancreatic cancer can enhance the intratumor concentration of certain anticancer drugs. Could this finding provide us with a new method to attack pancreatic cancer?
Insights
Inhibiting Hedgehog (Hh) signaling in mouse models of pancreatic cancer boosts anticancer drug levels within tumors. This discovery may offer a novel strategy for treating pancreatic cancer.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- Pancreatic cancer remains a significant health challenge with limited effective treatments.
- Hedgehog (Hh) signaling pathways are implicated in various cancers, including pancreatic cancer.
- Drug delivery and concentration within tumors are critical factors for therapeutic efficacy.
Purpose of the Study:
- To investigate the effect of inhibiting Hedgehog (Hh) signaling on the intratumoral concentration of anticancer drugs.
- To explore a potential new therapeutic strategy for pancreatic cancer by modulating Hh signaling.
Main Methods:
- Utilized a genetically engineered mouse model of pancreatic cancer.
- Administered inhibitors targeting the Hedgehog (Hh) signaling pathway.
- Quantified the concentration of specific anticancer drugs within tumor tissues.
Main Results:
- Inhibition of Hedgehog (Hh) signaling led to enhanced intratumoral concentrations of certain anticancer drugs.
- The study demonstrated a direct correlation between Hh pathway inhibition and improved drug accumulation in pancreatic tumors.
- No significant adverse effects were reported in the context of drug concentration enhancement.
Conclusions:
- Modulating Hedgehog (Hh) signaling presents a promising approach to improve the efficacy of existing anticancer drugs in pancreatic cancer.
- This strategy could overcome challenges related to poor drug penetration and concentration in pancreatic tumors.
- Further research is warranted to translate these findings into clinical applications for pancreatic cancer patients.
Related Concept Videos
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:21Acute Pancreatitis II: Pathophysiology
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
01:25Acute Pancreatitis I: Introduction
Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
01:27Acute Pancreatitis I: Introduction
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include: